Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Terminated(1)
Other(1)

Detailed Status

unknown1
Completed1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

unknown133%
completed133%
terminated133%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Prehospital Transfusion Strategy in Bleeding Patients

NCT04879485
unknown

Comparing TASH Score and Modified TBSS in Trauma Patients in Need for Massive Blood Transfusion

NCT06128057
terminatednot_applicable

ECM and Blood Components for Wound Healing

NCT01909908

Clinical Trials (3)

Showing 3 of 3 trials
NCT04879485Not Applicable

Prehospital Transfusion Strategy in Bleeding Patients

Completed
NCT06128057

Comparing TASH Score and Modified TBSS in Trauma Patients in Need for Massive Blood Transfusion

Unknown
NCT01909908Not Applicable

ECM and Blood Components for Wound Healing

Terminated

All 3 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
3